13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q2 2025. See the latest, Q2 2026 →
Reported value
$499.46B
+8.6% on the quarter before
Positions
431
31 new · 56 sold out
Top 10
36.3%
of the value
Est. gain
+$55.01B
on stocks held all quarter
Est. return
+13.8%
on those stocks since Q1 2025
Positions as of Jun 30, 2025, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 54% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2025. Striped tiles are options.
Largest buys
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$7.30BAdded · 2.3% → 4.5%+46,228,880 shares
- Eli Lilly~$3.90BAdded · 2.8% → 3.2%+5,008,900 shares
- Starbucks Corp~$3.78BAdded · 0.8% → 1.4%+41,264,059 shares
- Arista Networks~$1.40BAdded · 0.1% → 0.4%+13,675,163 shares
- Dominion Energy~$1.23BAdded · 0.3% → 0.5%+21,722,810 shares
- AT&T~$1.21BAdded · 0.1% → 0.4%+41,958,911 shares
- Microchip Technology~$1.10BNew · 0.0% → 0.2%+15,650,335 shares
- Halliburton Co~$1.02BAdded · 0.0% → 0.2%+50,044,791 shares
- Las Vegas Sands Corp~$959.9MAdded · 0.2% → 0.4%+22,061,525 shares
- Oracle~$881.9MAdded · 0.6% → 1.0%+4,033,717 shares
Largest sells
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Unitedhealth Group Inc~$4.70BCut · 2.4% → 0.4%−15,078,082 shares
- Gilead Sciences Inc~$2.61BCut · 1.3% → 0.7%−23,512,691 shares
- Salesforce~$2.56BCut · 1.2% → 0.6%−9,395,611 shares
- GE HealthCare~$2.31BCut · 0.9% → 0.3%−31,220,666 shares
- Alphabet~$1.77BCut · 1.8% → 1.5%−10,062,090 shares
- Alphabet~$1.55BCut · 1.2% → 1.0%−8,737,186 shares
- Shopify Inc~$1.55BCut · 0.5% → 0.2%−13,434,719 shares
- Microsoft~$1.55BCut · 6.1% → 7.1%−3,106,934 shares
- Abbvie Inc~$1.53BCut · 1.5% → 0.9%−8,242,435 shares
- Meta~$1.38BCut · 4.3% → 4.8%−1,867,880 shares
Holdings
As of Jun 30, 2025. Changes are in shares against Mar 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −4.1% · price +32.5% | 7.1% | $35.70B | +$8.76B | ||||||||
| BroadcomCOM · shares +2.3% · price +64.6% | 5.1% | $25.23B | +$9.68B | ||||||||
| MetaCL A · shares −5.4% · price +28.1% | 4.8% | $23.96B | +$5.25B | ||||||||
| NvidiaCOM · shares +48% · price +45.8% | 4.5% | $22.51B | +$4.77B | ||||||||
| AmazonCOM · shares −1.4% · price +15.3% | 3.7% | $18.58B | +$2.47B | ||||||||
| Eli LillyCOM · shares +32% · price −5.6% | 3.2% | $16.18B | −$730.4M | ||||||||
| UberCOM · shares +0.2% · price +28.1% | 2.2% | $11.22B | +$2.45B | ||||||||
| Rtx CorporationCOM · shares −3.1% · price +10.2% | 2.2% | $11.01B | +$1.02B | ||||||||
| AppleCOM · shares −14% · price −7.6% | 1.7% | $8.57B | −$708.1M | ||||||||
| Royal Caribbean GroupCOM · shares +11% · price +52.4% | 1.6% | $8.10B | +$2.51B | ||||||||
| Ge AerospaceCOM NEW · shares −11% · price +28.6% | 1.6% | $7.77B | +$1.73B | ||||||||
| AlphabetCAP STK CL A · shares −19% · price +14.0% | 1.5% | $7.73B | +$946.9M | ||||||||
| Philip Morris Intl IncCOM · shares −9.5% · price +14.7% | 1.5% | $7.40B | +$950.9M | ||||||||
| Boeing CoCOM · shares −13% · price +22.9% | 1.5% | $7.27B | +$1.35B | ||||||||
| Vertex Pharmaceuticals IncCOM · shares +11% · price −8.2% | 1.4% | $7.17B | −$576.1M | ||||||||
| Starbucks CorpCOM · shares +116% · price −6.6% | 1.4% | $7.03B | −$228.8M | ||||||||
| Jpmorgan Chase & Co.COM · shares +9.9% · price +18.2% | 1.4% | $6.81B | +$954.4M | ||||||||
| NetflixCOM · shares +4.5% · price +43.6% | 1.3% | $6.34B | +$1.84B | ||||||||
| Abbott LabsCOM · shares −18% · price +2.5% | 1.1% | $5.68B | +$140.3M | ||||||||
| Carrier GlobalCOM · shares −6.4% · price +15.4% | 1.1% | $5.51B | +$736.5M | ||||||||
| MastercardCL A · shares −4.9% · price +2.5% | 1.1% | $5.46B | +$134.2M | ||||||||
| OracleCOM · shares +21% · price +56.4% | 1.0% | $5.04B | +$1.50B | ||||||||
| AlphabetCAP STK CL C · shares −24% · price +13.5% | 0.98% | $4.88B | +$581.7M | ||||||||
| Abbvie IncCOM · shares −25% · price −11.4% | 0.94% | $4.69B | −$603.9M | ||||||||
| MercadoLibreCOM · shares −21% · price +33.9% | 0.92% | $4.59B | +$1.16B | ||||||||
| Total · 431 positions | 100% | $499.46B | +$55.01B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2025 to Q2 2025: 399 stocks held throughout, up $55.01B (+13.8%).
- Broadcom+$9.68B+65%
- Microsoft+$8.76B+33%
- Meta+$5.25B+28%
- Nvidia+$4.77B+46%
- Royal Caribbean Group+$2.51B+52%
- Vertex Pharmaceuticals Inc−$576.1M−8%
- Abbvie Inc−$603.9M−11%
- Apple−$708.1M−8%
- Eli Lilly−$730.4M−6%
- Unitedhealth Group Inc−$1.22B−40%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |